PRIMROSE BIO
Primrose Bio is a biotech company that focuses on discovery, development, and manufacturing of new molecules. innovative therapeutics, vaccines and ingredients to aevance global health.
PRIMROSE BIO
Industry:
Biotechnology Therapeutics
Founded:
2023-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.primrosebio.com
Status:
Active
Total Funding:
15 M USD
Technology used in webpage:
Cloudflare Hosting
Founder
Official Site Inspections
http://www.primrosebio.com Semrush global rank: 13.65 M Semrush visits lastest month: 75
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Primrose Bio"
About Us - Primrose Bio, Inc.
As a fully integrated CMC organization, weโre suited to ensure your success. LEADERSHIP. Board & ADVISORS. Our Heritage. We have established more than 100 collaborations, working alongside a diverse range of partners from โฆSee details»
Our Team - Primrose Bio, Inc.
CFO | Simon Latimer Simon oversees the finance and accounting functions at Primrose Bio. Prior to joining Primrose, he was the head of corporate development and investor relations at โฆSee details»
Manufacturing Solutions for Biotherapeutics and Vaccines
Sep 3, 2024 The PeliCRM197® Carrier Protein. Produced using our Pfenex Expression Technology, PeliCRM197 is the industry leading CRM197 in the market used in conjugate โฆSee details»
Primrose Bio - Crunchbase Company Profile & Funding
Primrose Bio is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.See details»
Primrose Bio - LinkedIn
Primrose Bio offers radically new products and tools that unlock unexplored possibilities for the discovery, development, and manufacturing of new molecules.See details»
Introducing Primrose Bio: Enabling Innovative Therapeutic
Sep 18, 2023 Primrose Bio combines the Function Generatorโข and Pelican Expression Technology ® (formerly Pfenex Expression Technology ®) platforms of its founding companies โฆSee details»
Introducing Primrose Bio: Enabling Innovative โฆ
Sep 18, 2023 /PRNewswire/ -- Primrose Bio, Inc., a stand-alone private biotechnology company focused on developing state-of-the-art discovery and production systems for...See details»
Introducing Primrose Bio: Enabling Innovative Therapeutic โฆ
Sep 18, 2023 Primrose Bio's technologies have been leveraged to launch Prima RNApolsโข and PeliCRM197 ®, two widely licensed manufacturing and formulation solutions for biopharma โฆSee details»
Primrose Bio Announces Investment from 1315 Capital to Advance ...
Jun 18, 2024 โWe are thrilled to have the support of such a high-quality organization and team at 1315 Capital who share our vision of expanding opportunities in biomanufacturing โฆSee details»
Primrose Bio Announces Investment from 1315 Capital โฆ
SAN DIEGO, June 17, 2024 /PRNewswire/ -- Primrose Bio, Inc. ("Primrose," the "Company"), a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins ...See details»
Primrose Bio Announces Investment from 1315 Capital to Advance ...
Jun 17, 2024 โWe are thrilled to have the support of such a high-quality organization and team at 1315 Capital who share our vision of expanding opportunities in biomanufacturing โฆSee details»
Intravacc and Primrose Bio Announce Partnership to Enhance โฆ
Mar 28, 2024 The companies will leverage their combined experience in the development of conjugate vaccines for their clientsPrimrose Bio will supply its industry-leading carrier protein, โฆSee details»
Primrose Bio Announces Investment from 1315 Capital to Advance ...
Jun 17, 2024 Primrose Bio, Inc. ("Primrose," the "Company"), a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in โฆSee details»
Intravacc And Primrose Bio Announce Partnership To Enhance โฆ
Mar 28, 2024 <p>Intravacc, a leading global contract development and manufacturing organization (CDMO) specializing in infectious disease and therapeutic vaccines, and โฆSee details»
BPI News: Primrose Bio Blossoms from Pelican and Primordial โฆ
Sep 20, 2023 The development of state-of-the-art discovery and production systems for protein and nucleic acid medicines is exactly where Zieler is calibrating his newly formed company, โฆSee details»
Primrose Bio Announces Investment from 1315 Capital to Advance ...
Jun 17, 2024 "We are thrilled to have the support of such a high-quality organization and team at 1315 Capital who share our vision of expanding opportunities in biomanufacturing โฆSee details»
Introducing Primrose Bio: Enabling Innovative Therapeutic โฆ
SAN DIEGO, Sept. 18, 2023 /PRNewswire/ โ Primrose Bio, Inc., a stand-alone private biotechnology company focused on developing state-of-the-art discovery and production โฆSee details»
Primrose Bio Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Primrose Bio. Use the PitchBook Platform to explore the full profile.See details»
Intravacc and Primrose Bio Announce Partnership to Enhance
Mar 28, 2024 Primrose Bio will supply its industry-leading carrier protein, PeliCRM197 ®, for vaccine development; Intravacc has IP and know-how in vaccine conjugation and โฆSee details»
Primrose Bio Receives Investment from 1315 Capital - FinSMEs
Jun 18, 2024 Primrose Bio, a San Diego, CA-based company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in therapeutics โฆSee details»